Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × balstilimab × Clear all

NCT06843551 2025-08-14

EMPIRE

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT05638698 2024-09-23

TESLA

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms